XAVERZAL, created in 2014 (United States), from 584 sister brands and 17477 competing brands. The XAVERZAL brand is owned by ASTRAZENECA, a company listed in London. Its International Securities Identification Number (ISIN) is GB0009895292. The sector of XAVERZAL is Drug Manufacturers.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(XAVERZAL)
over 5 years*
GBX 25,222.16